Revenue
YoY +23.1%$1.5B TTM$411.5M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
TEM
$75.61-2.81%
as of close, Nov 4, 2026
☾ AH $75.61 -2.81%
Tempus AI Inc.Stock · HealthcareNasdaq Composite · 0.02% of ONEQUS Stock Market · 0.009% of VTIRussell 1000 · 0.009% of IWBRussell 3000 · 0.009% of IWV
Head-to-head:Compare with VEEV or any ticker →
TEM financial statements
The full income statement, balance sheet, and cash-flow statement for Tempus AI Inc. (TEM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Financial overview#
Operating income
YoY n/m−$278.9M TTM−$56.9M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Net income
YoY n/m−$189.3M TTM−$14.9M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS (diluted)
YoY n/m−$1.05 TTM−$0.08 Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Operating cash flow
YoY n/m−$108.4M TTM$9.2M Q3 '26
FY22FY23FY24FY25TTM
Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Capital expenditure
YoY +83.4%$42.3M TTM$14.8M Q3 '26
FY22FY23FY24FY25TTM
Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Free cash flow
YoY n/m−$150.6M TTM−$5.5M Q3 '26
FY22FY23FY24FY25TTM
Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares (diluted)
YoY +3.6%180.2M TTM181.3M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Dividend per share
— FY25
FY22FY23FY24FY25
No quarters filed for this figure.
Shares outstanding (point-in-time)
2024-09 157.4M2024-12 172.2M2025-03 173.1M2025-06 173.7M2025-09 177.9M2025-12 178.8M2026-03 179.6M2026-06 180.4M2026-09 182.4M+15.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Revenue | 1.27B+83.4% | 693M+30.4% | 532M+65.8% | 321M | |
| Research & development | 173M+15.8% | 149M+65.3% | 90.3M+8.6% | 83.2M | |
| Selling, general & administrative | 732M-3.1% | 755M+154.5% | 297M+27.2% | 233M | |
| Provision for credit losses | 2.56M+276.2% | 680K-58.7% | 1.65M-57.4% | 3.87M | |
| Operating income | -253M+63.4% | -691M-252.4% | -196M+26.1% | -265M | |
| Interest expense | 70.3M+31.0% | 53.7M+14.5% | 46.9M+114.1% | 21.9M | |
| Interest & investment income | 12.6M+13.9% | 11.1M+45.8% | 7.60M+150.7% | 3.03M | |
| Other non-operating income | 31.4M-2.7% | 32.3M+48.2% | 21.8M+550.3% | -4.85M | |
| Equity-method income | -5.61M-32.8% | -4.23M-1304.7% | -301K+49.4% | -595K | |
| Gain (loss) on equity securities | 16.5M+36.0% | 12.1M+23.5% | 9.81M | 0.00 | |
| Pre-tax income | -291M+58.5% | -701M-228.4% | -214M+26.2% | -289M | |
| Income tax | -51.7M-19530.1% | 266K-7.6% | 288K+336.4% | 66.0K | |
| -245M+65.3% | -706M-229.6% | -214M+26.1% | -290M | ||
| Net income to common | -245M+67.2% | -746M-180.6% | -266M+20.4% | -334M | |
| -$1.41+77.4% | -$6.23-48.3% | -$4.20+20.8% | -$5.30 | ||
| EPS (basic) | -$1.41+77.4% | -$6.23-48.3% | -$4.20+20.8% | -$5.30 | |
| Weighted-avg shares (basic) | 174M+45.4% | 120M+89.3% | 63.3M+0.4% | 63.0M | |
| Weighted-avg shares (diluted) | 174M+45.4% | 120M+89.3% | 63.3M+0.4% | 63.0M | |
| Dividends per share | — | $0.05-47.2% | $0.09-0.4% | $0.09 | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 1.17B+74.8% | 668M+90.6% | 350M | — | ||
| Cash & equivalents | 605M+77.4% | 341M+105.7% | 166M-45.4% | 304M | |
| Accounts receivable | 311M+101.0% | 155M+63.9% | 94.5M | — | |
| Inventory | 51.7M+34.7% | 38.4M+33.1% | 28.8M | — | |
| Prepaid expenses | 40.5M+55.0% | 26.1M+51.1% | 17.3M | — | |
| 2.27B+145.6% | 926M+64.2% | 564M | — | ||
| Property, plant & equipment | 89.2M+53.6% | 58.1M-5.9% | 61.7M | — | |
| Operating lease right-of-use | 64.5M+336.9% | 14.8M-28.1% | 20.5M | — | |
| Goodwill | 470M+541.1% | 73.3M-0.0% | 73.4M+38.1% | 53.1M | |
| Intangible assets | 349M+2880.6% | 11.7M-46.5% | 21.9M | — | |
| 372M+27.9% | 291M+25.1% | 233M | — | ||
| Accounts payable | 82.0M+52.4% | 53.8M-1.1% | 54.4M | — | |
| Accrued liabilities | 155M+19.1% | 130M+58.0% | 82.5M | — | |
| Deferred revenue | 92.7M+22.0% | 76.0M+17.1% | 64.9M | — | |
| Current lease liability | 13.4M+106.8% | 6.46M+0.3% | 6.44M | — | |
| Other current liabilities | 8.68M+24.6% | 6.96M-15.2% | 8.21M | — | |
| 1.78B+105.1% | 870M+3.5% | 841M | — | ||
| Long-term debt | 1.24B+184.7% | 435M-3.2% | 450M | — | |
| Deferred revenue (non-current) | 20.4M+203.7% | 6.71M-60.0% | 16.8M | — | |
| Non-current lease liability | 74.3M+183.5% | 26.2M-18.2% | 32.0M | — | |
| Operating lease liability (total) | 87.6M+168.3% | 32.7M | — | — | |
| Other non-current liabilities | 56.6M+254.2% | 16.0M-19.1% | 19.8M | — | |
| 491M+772.1% | 56.3M+104.1% | -1.38B-22.4% | -1.13B | ||
| Additional paid-in capital | 2.89B+30.9% | 2.21B+11950.5% | 18.3M | — | |
| Retained earnings | -2.40B-11.4% | -2.15B-54.0% | -1.40B | — | |
| Treasury stock | 6.64M+84.4% | 3.60M+0.0% | 3.60M | — | |
| Accumulated other comprehensive income | 902K+859.6% | 94.0K | — | — | |
| Total liabilities & equity | 2.27B+145.6% | 926M+64.2% | 564M | — | |
| Treasury shares | 183K+26.0% | 145K+0.0% | 145K | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| -218M-15.4% | -189M+11.8% | -214M-27.4% | -168M | ||
| Depreciation & amortization | 102M+174.7% | 37.2M+12.7% | 33.0M+10.1% | 30.0M | |
| Share-based compensation | 125M-76.6% | 534M | 0.00 | 0.00 | |
| Deferred income taxes | -52.7M | 0.00 | 0.00 | — | |
| Change in receivables | 90.4M+48.1% | 61.0M+730.8% | 7.35M-10.4% | 8.20M | |
| Change in inventory | 3.37M-64.7% | 9.54M+45.4% | 6.56M+400.2% | 1.31M | |
| Change in payables | -7.24M+69.6% | -23.9M-2.1% | -23.4M-195.2% | -7.92M | |
| -398M-205.5% | -130M-223.4% | -40.3M+30.4% | -57.9M | ||
| Capital expenditure | 27.3M+23.3% | 22.1M-36.1% | 34.6M+88.3% | 18.4M | |
| Free cash flow | -245M-16.2% | -211M+15.2% | -249M-33.4% | -187M | |
| Acquisitions | 377M | 0.00-100.0% | 5.71M-85.6% | 39.6M | |
| 884M+78.9% | 494M+320.5% | 118M-53.2% | 251M | ||
| Long-term debt issued | 196M | 0.00-100.0% | 82.9M-51.4% | 171M | |
| Long-term debt repaid | 277M | 0.00 | 0.00 | 0.00 | |
| Common stock issued | — | — | 0.00 | 0.00 | |
| Common stock repurchased | 3.04M | 0.00-100.0% | 3.60M | 0.00 | |
| Dividends paid | 0.00-100.0% | 5.63M+0.0% | 5.63M+0.0% | 5.63M | |
| FX effect on cash | -62.0K-118.5% | 336K+1868.4% | -19.0K-211.8% | 17.0K | |
| Net change in cash | 268M+52.7% | 175M+227.8% | -137M-642.7% | 25.3M | |
| Interest paid | 44.0M+57.0% | 28.0M+65.8% | 16.9M+262.6% | 4.66M | |
| Income taxes paid | 654K+217.5% | 206K+28.0% | 161K+2583.3% | 6.00K | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Market cap | 10.6B+81.6% | 5.81B | — | — | |
| P/S | 8.3×-1.0% | 8.4× | — | — | |
| P/B | 21.5×-79.2% | 103.2× | — | — | |
| Dividend yield | — | 0.14% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K |
About this data
Source: TEM’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TEM filings on SEC EDGAR → Not investment advice.
Head-to-head:Compare with VEEV or any ticker →